The Role of Ficolins in Lung Injury

Overview

Journal J Innate Immun

Publisher Karger

Specialty Allergy & Immunology

Date 2024 Aug 19

PMID 39159606

Authors

Meiyun Zhao

Xiaowu Tan

Xu Wu

Affiliations

Soon will be listed here.

Abstract

Background: Respiratory diseases seriously threaten human health worldwide, and lung injury is an important component of respiratory disease. Complement activation is an important function of the innate immune system. Complement activation helps the body defend against invasion by external microorganisms, whereas excessive complement activation can exacerbate tissue damage or lead to unwanted side effects. Ficolins are a class of immune-related proteins in the lectin pathway that play important roles in the body's immune defense. Although individual ficolins are not well understood, current information suggests that ficolins may play an important regulatory role in lung injury.

Summary: Several studies have shown that ficolins are involved in the immune response in the lung, particularly in the response to infectious and inflammatory processes.

Key Messages: This review summarizes the role of ficolins in lung injury. Ficolins may influence the development and repair of lung injury by recognizing and binding pathogenic microorganisms, modulating the inflammatory response, and promoting the clearance of immune cells. In addition, ficolins are associated with the development and progression of lung diseases (such as pneumonia and ARDS) and may have an important impact on the pathophysiological processes of inflammatory diseases.

References

Osthoff M, Ngian G, Dean M, Nikpour M, Stevens W, Proudman S . Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study. Arthritis Res Ther. 2014; 16(6):480. PMC: 4264552. DOI: 10.1186/s13075-014-0480-6. View

Xu D, Wang C, Jiang F, Wei L, Shi L, Yu X . Association of the FCN2 Gene Single Nucleotide Polymorphisms with Susceptibility to Pulmonary Tuberculosis. PLoS One. 2015; 10(9):e0138356. PMC: 4574923. DOI: 10.1371/journal.pone.0138356. View

Vogt S, Trendelenburg M, Tamm M, Stolz D, Hostettler K, Osthoff M . Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases. Front Immunol. 2020; 11:562564. PMC: 7546814. DOI: 10.3389/fimmu.2020.562564. View

Endo Y, Matsushita M, Fujita T . The role of ficolins in the lectin pathway of innate immunity. Int J Biochem Cell Biol. 2011; 43(5):705-12. DOI: 10.1016/j.biocel.2011.02.003. View

Verma A, White M, Vathipadiekal V, Tripathi S, Mbianda J, Ieong M . Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses. J Immunol. 2012; 189(5):2478-87. PMC: 3650843. DOI: 10.4049/jimmunol.1103786. View

Bidula S, Sexton D, Schelenz S . Serum opsonin ficolin-A enhances host-fungal interactions and modulates cytokine expression from human monocyte-derived macrophages and neutrophils following Aspergillus fumigatus challenge. Med Microbiol Immunol. 2015; 205(2):133-42. DOI: 10.1007/s00430-015-0435-9. View

Hummelshoj T, Munthe-Fog L, Madsen H, Fujita T, Matsushita M, Garred P . Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Hum Mol Genet. 2005; 14(12):1651-8. DOI: 10.1093/hmg/ddi173. View

Gersuk G, Underhill D, Zhu L, Marr K . Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J Immunol. 2006; 176(6):3717-24. DOI: 10.4049/jimmunol.176.6.3717. View

Miyagawa T, Asano Y, de Mestier Y, Saigusa R, Taniguchi T, Yamashita T . Serum H-ficolin levels: Clinical association with interstitial lung disease in patients with systemic sclerosis. J Dermatol. 2017; 44(10):1168-1171. DOI: 10.1111/1346-8138.13877. View

10.

Chalmers J, Fleming G, Rutherford J, Matsushita M, Kilpatrick D, Hill A . Serum ficolin-2 in hospitalised patients with community-acquired pneumonia. Inflammation. 2014; 37(5):1635-41. DOI: 10.1007/s10753-014-9891-4. View

11.

Akaiwa M, Yae Y, Sugimoto R, Suzuki S, Iwaki T, Izuhara K . Hakata antigen, a new member of the ficolin/opsonin p35 family, is a novel human lectin secreted into bronchus/alveolus and bile. J Histochem Cytochem. 1999; 47(6):777-86. DOI: 10.1177/002215549904700607. View

12.

Pan Q, Chen H, Wang F, Jeza V, Hou W, Zhao Y . L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits influenza A virus infection both in vitro and in vivo. J Innate Immun. 2012; 4(3):312-24. PMC: 6741490. DOI: 10.1159/000335670. View

13.

Yuste J, Botto M, Paton J, Holden D, Brown J . Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia. J Immunol. 2005; 175(3):1813-9. DOI: 10.4049/jimmunol.175.3.1813. View

14.

Schlapbach L, Thiel S, Kessler U, Ammann R, Aebi C, Jensenius J . Congenital H-ficolin deficiency in premature infants with severe necrotising enterocolitis. Gut. 2010; 60(10):1438-9. DOI: 10.1136/gut.2010.226027. View

15.

Endo Y, Liu Y, Kanno K, Takahashi M, Matsushita M, Fujita T . Identification of the mouse H-ficolin gene as a pseudogene and orthology between mouse ficolins A/B and human L-/M-ficolins. Genomics. 2004; 84(4):737-44. DOI: 10.1016/j.ygeno.2004.07.006. View

16.

Schelenz S, Kirchhof N, Bidula S, Wallis R, Sexton D . Opsonizing properties of rat ficolin-A in the defence against Cryptococcus neoformans. Immunobiology. 2012; 218(4):477-83. DOI: 10.1016/j.imbio.2012.06.006. View

17.

Venkatraman Girija U, Mitchell D, Roscher S, Wallis R . Carbohydrate recognition and complement activation by rat ficolin-B. Eur J Immunol. 2010; 41(1):214-23. PMC: 3179595. DOI: 10.1002/eji.201040612. View

18.

Garlatti V, Martin L, Lacroix M, Gout E, Arlaud G, Thielens N . Structural insights into the recognition properties of human ficolins. J Innate Immun. 2010; 2(1):17-23. DOI: 10.1159/000233475. View

19.

Amarante-Mendes G, Adjemian S, Branco L, Zanetti L, Weinlich R, Bortoluci K . Pattern Recognition Receptors and the Host Cell Death Molecular Machinery. Front Immunol. 2018; 9:2379. PMC: 6232773. DOI: 10.3389/fimmu.2018.02379. View

20.

Paton J, Rowan-Kelly B, Ferrante A . Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun. 1984; 43(3):1085-7. PMC: 264298. DOI: 10.1128/iai.43.3.1085-1087.1984. View